Leadership

Executive Team

Thomas B. Neff
Chairman, Founder, Chief Executive Officer

Pat Cotroneo
Vice President, Finance, and Chief Financial Officer

Stephen J. Klaus, Ph.D.
Vice President, Drug Development, Global Anemia Project Leader

Melissa Grigorieff Koomey
Vice President, Marketing, Corporate Communications and Investor Relations

Al Lin, MD, Ph.D.
Vice President, Preclinical Development and Chemical Manufacturing and Control (CMC)

David Y. Liu, Ph.D.
Vice President, Research

Claire J. Lockey
Vice President, Regulatory Affairs

Michael D. Lowenstein
Vice President, Legal Affairs

James W. Polarek, Ph.D.
Vice President, Protein Therapeutics and Collagen Development

Leanne C. Price
Vice President, Intellectual Property

Ted Tucker
Vice President, Human Resources

Frank H. Valone, MD
Chief Medical Officer

K. Peony Yu, MD
Vice President, Clinical Development

Board of Directors

Thomas B. Neff
Chairman, Founder, Chief Executive Officer

Thomas F. Kearns Jr.
Retired Partner, Bear, Stearns & Co., Inc.

Kalevi Kurkijärvi Ph.D.
Senior Partner, Chairman and CEO, BioFund Management Fund Ltd.

Miguel Madero
Fomento Direccion, Mexico

Rory B. Riggs
Managing Member, Balfour LLC; Former President and Director, Biomatrix, Inc.

Jorma Routti, Ph.D.
Chairman of the Board of Directors, FibroGen Europe, Former Director General of the Directorate of Science, Research and Development of the European Commission

Julian N. Stern
Counsel to Goodwin Procter, LLP.

Toshinari Tamura, Ph.D.
Former Representative Director, Executive Vice President and Chief Science Officer of Astellas Pharma, Inc.

Julius A. Vida, Ph.D., M.B.A.
Former Vice President, Business Development, Licensing and Strategic Planning of Bristol-Myers Squibb Co.
Founder and President of Vida International Pharmaceutical Consultants